Joseph Schwartz


Aurinia Pharmaceuticals Inc’s (AUPH) Voclosporin Continues to Filter Out Bearish Concern: Top Analyst

Yesterday, Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) presented data at the European Lupus Meeting, which indicates 70% of patients achieved complete remission (CR) at 24 …

Intercept Pharmaceuticals Announces Two New Sub-Groups for FLINT Trial; Analysts Comment

Intercept Pharmaceuticals Inc (NASDAQ: ICPT) is a biopharmaceutical company known for developing drug treatments for chronic liver diseases. The company’s current leading drug is …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts